Innoviva (INVA) Dividends Paid - Common Growth (3y) (2017 - 2022)
Innoviva (INVA) Dividends Paid - Common Growth (3y) (2017 - 2022) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Div. Paid (Common) Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
- |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
- |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
- |
| 10 |
Innoviva |
1.65 Bn |
1.05 Bn |
75.83 Mn |
- |
| Date | Value |
|---|
| Jun 30, 2022 |
1,370.90% |
| Mar 31, 2022 |
833.46% |
| Sep 30, 2021 |
185.65% |
| Jun 30, 2021 |
186.09% |
| Mar 31, 2021 |
724.32% |
| Dec 31, 2020 |
107.54% |
| Jun 30, 2020 |
572.25% |
| Mar 31, 2020 |
517.95% |
| Dec 31, 2019 |
445.34% |
| Jun 30, 2019 |
-71.08% |
| Mar 31, 2019 |
-77.68% |
| Dec 31, 2018 |
154.07% |
| Sep 30, 2018 |
-59.11% |
| Jun 30, 2018 |
-69.12% |
| Mar 31, 2018 |
-89.03% |
| Dec 31, 2017 |
-78.59% |
| Sep 30, 2017 |
-26.07% |
